| 201 |
WELIDX |
BELZUTIFAN 40 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH VON HIPPEL-LINDAU DISEASE WHO REQUIRE THERAPY FOR ASSOCIATED RENAL CELL CARCINOMA, CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS, OR PANCREATIC NEUROENDROCRINE TUMORS, NOT REQUIRING IMMIDIATE SURGERY |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1208/24 |
2024-10-03 |
2029-10-02 |
View |
| 202 |
BRATODX |
ENCORAFENIB 75 MG |
CAPSULE |
BOTTLE |
IN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH A BRAF V600E OR V600K MUTATION |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1201/24 |
2024-09-24 |
2029-09-23 |
View |
| 203 |
LUTRODX |
LUSUTROMBOPAG 3 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE WHO ARE SCHEDULED TO UNDERGO A PROCEDURE |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1202/24 |
2024-09-24 |
2029-09-23 |
View |
| 204 |
TEPODX |
TEPOTINIB 225 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1200/24 |
2024-09-24 |
2029-09-23 |
View |
| 205 |
REPODX |
REPOTRECTINIB 40 MG |
CAPSUEL |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC ROS1 POSITIVE NON SMALL CELL LUNG CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1203/24 |
2024-09-24 |
2029-09-23 |
View |
| 206 |
FEBUSODX |
FEBUXOSTAT 40 MG |
TABLET |
BOTTLE |
FOR THE CHRONIC MANAGEMENT OF HYPERURICEMIA IN ADULT PATIENTS WITH GOUT WHO HAVE AN INADEQUAT RESPONSE TO A MAXIMALLY TITRATED DOSE OF ALLOPURINOL, WHO ARE INTOLERANT TO ALLOPURINOL OR FOR WHOM TREATMENT WITH ALLOPURINOL IS NOT ADVISABLE |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1199/24 |
2024-10-03 |
2029-10-02 |
View |
| 207 |
LENVIDX |
LENVATINIB 4 MG |
CAPSULE |
BOTTLE |
TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1155/24 |
2024-08-07 |
2027-08-06 |
View |
| 208 |
LENVIDX |
LENVATINIB 10 MG |
CAPSULE |
BOTTLE |
TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1156/24 |
2024-08-07 |
2027-08-06 |
View |
| 209 |
PRASEDX |
PRALSETINIB 100 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF ADULTS PATIENTS WITH METASTATIC RET FUSION POSITIVE NON SMALL CELL LUNG CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1157/24 |
2024-08-07 |
2027-08-06 |
View |
| 210 |
OLADX |
OLAPARIB 150 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OVARIAN CANCER, BREAST CANCER, PANCREATIC CANCER, PROSTATE CANCER |
No |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1148/24 |
29-ก.ค.-2024 |
28-ก.ค.-2027 |
View |
